+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)

  • PDF Icon

    Report

  • 206 Pages
  • January 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5990128
The publisher has released a research report titled “Global OC/LEP Market (2024 Edition)” which provides a Combination Contraceptives Pills analysis of the Global OC/LEP industry in terms of market segmentation By Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The Global OC/LEP market showcased growth at a CAGR of 4.59% during 2020-2023. The market was valued at USD 16.30 Billion in 2023 which is expected to reach USD 22.95 Billion in 2030.

The global OC/LEP market has been experiencing significant growth. This expansion is driven by increasing awareness of family planning, rising demand for effective contraceptive methods, and greater accessibility to healthcare services. Low estrogen pills are favoured due to their reduced risk of side effects compared to traditional higher-dose pills, making them a preferred choice for many women seeking hormonal birth control options.

There is an increasing awareness about reproductive health and contraceptive options among women globally. Educational campaigns by governments and non-profit organizations have significantly contributed to the understanding of oral contraceptives, promoting their use as a reliable method of preventing unwanted pregnancies.

Additionally, Modern lifestyles and changing demographics, including delayed childbirth and an increase in the number of working women, have driven the demand for convenient and effective contraceptive methods. Oral contraceptives offer an easy-to-use solution that fits into the busy lives of modern women.

Moreover, Government policies supporting family planning and reproductive health have also played a crucial role. Subsidies and healthcare initiatives that make contraceptives more affordable and accessible are significant drivers of market growth.

Scope of the Report

  • The report analyses the OC/LEP Market by Value ( USD Billion).
  • The report analyses the OC/LEP Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, China, Japan, India).
  • The report presents the analysis of OC/LEP Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the OC/LEP Market by Type (Combination Contraceptives Pills, Progestin-only Pills)
  • The report analyses the OC/LEP Market by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Distribution Channel and By Drug Class.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer AG, Merck & Co., Inc., Teva Pharmaceuticals, Abbvie, Viatris, and Cipla.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Personalized Solutions
2.2 Male Oral Contraceptive
3. Global OC/LEP Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global OC/LEP Market3. Global OC/LEP Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global OC/LEP Market
3.2 Unintended pregnancy and abortion rates, by region, 2015-2022
3.3 Global number of women of reproductive age contraceptive use and unmet need 1990 and 2021 (millions)
3.4 Contraceptive use (modern and traditional) and unmet need for family planning among women with a need for family planning, world and by region, 2021
3.5 Global OC/LEP Market: Dashboard
3.6 Global OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.7 Global OC/LEP Market: Market Value Assessment
3.8 Assessment Degree of Impact of COVID-19 on Global OC/LEP Market
3.9 Global OC/LEP Market Segmentation: By Type
3.9.1 Global OC/LEP Market, By Type Overview
3.9.2 Global OC/LEP Market Attractiveness Index, By Type
3.9.3 Global OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.4 Global OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billion & CAGR)
3.10 Global OC/LEP Market Segmentation: By Distribution Channel
3.10.1 Global OC/LEP Market, By Distribution Channel Overview
3.10.2 Global OC/LEP Market Attractiveness Index, By Distribution Channel
3.10.3 Global OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billion & CAGR)
4. OC/LEP Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas OC/LEP Market: Historic and Forecast
5.1 Americas OC/LEP Market: Snapshot
5.2 Americas OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas OC/LEP Market: Key Factors
5.4 Americas OC/LEP Market: Segment Analysis
5.5 Americas OC/LEP Market Segmentation: By Type
5.5.1 Americas OC/LEP Market, By Type Overview
5.5.2 Americas OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas OC/LEP Market Segmentation: By Distribution Channel
5.6.1 Americas OC/LEP Market, By Distribution Channel Overview
5.6.2 Americas OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas OC/LEP Market Segmentation: By Country
5.7.1 Americas OC/LEP Market, by Country Overview
5.7.2 United States OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.2.1 United States OC/LEP Market, By Type
5.7.2.2 United States OC/LEP Market, By Distribution Channel
5.7.3 Canada OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.3.1 Canada OC/LEP Market, By Type
5.7.3.2 Canada OC/LEP Market, By Distribution Channel
5.7.4 Rest of Americas OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.5.1 Rest of Americas OC/LEP Market, By Type
5.7.5.2 Rest of Americas OC/LEP Market, By Distribution Channel
6. Europe OC/LEP Market: Historic and Forecast
6.1 Europe OC/LEP Market: Snapshot
6.2 Europe OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe OC/LEP Market: Key Factors
6.4 Europe OC/LEP Market: Segment Analysis
6.5 Europe OC/LEP Market Segmentation: By Type
6.5.1 Europe OC/LEP Market, By Type Overview
6.5.2 Europe OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe OC/LEP Market Segmentation: By Distribution Channel
6.6.1 Europe OC/LEP Market, By Distribution Channel Overview
6.6.2 Europe OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe OC/LEP Market Segmentation: By Country
6.7.1 Europe OC/LEP Market, by Country Overview
6.7.2 United Kingdom OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.2.1 United Kingdom OC/LEP Market, By Type
6.7.2.2 United Kingdom OC/LEP Market, By Distribution Channel
6.7.3 Germany OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.3.1 Germany OC/LEP Market, By Type
6.7.3.2 Germany OC/LEP Market, By Distribution Channel
6.7.4 France OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.4.1 France OC/LEP Market, By Type
6.7.4.2 France OC/LEP Market, By Distribution Channel
6.7.5 Italy OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.5.1 Italy OC/LEP Market, By Type
6.7.5.2 Italy OC/LEP Market, By Distribution Channel
6.7.6 Netherlands OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Netherlands OC/LEP Market, By Type
6.7.6.2 Netherlands OC/LEP Market, By Distribution Channel
6.7.6 Rest of Europe OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Rest of Europe OC/LEP Market, By Type
6.7.6.2 Rest of Europe OC/LEP Market, By Distribution Channel
7. Asia Pacific OC/LEP Market: Historic and Forecast
7.1 Asia Pacific OC/LEP Market: Snapshot
7.2 Asia Pacific OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific OC/LEP Market: Key Factors
7.4 Asia Pacific OC/LEP Market: Segment Analysis
7.5 Asia Pacific OC/LEP Market Segmentation: By Type
7.5.1 Asia Pacific OC/LEP Market, By Type Overview
7.5.2 Asia Pacific OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific OC/LEP Market Segmentation: By Distribution Channel
7.6.1 Asia Pacific OC/LEP Market, By Distribution Channel Overview
7.6.2 Asia Pacific OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific OC/LEP Market Segmentation: By Country
7.7.1 Asia Pacific OC/LEP Market, by Country Overview
7.7.2 China OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.2.1 China OC/LEP Market, By Type
7.7.2.2 China OC/LEP Market, By Distribution Channel
7.7.3 Japan OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.3.1 Japan OC/LEP Market, By Type
7.7.3.2 Japan OC/LEP Market, By Distribution Channel
7.7.4 India OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.4.1 India OC/LEP Market, By Type
7.7.4.2 India OC/LEP Market, By Distribution Channel
7.7.5 Rest of Asia Pacific OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.5.1 Rest of Asia Pacific OC/LEP Market, By Type
7.7.5.2 Rest of Asia Pacific OC/LEP Market, By Distribution Channel
8. Middle East & Africa OC/LEP Market: Historic and Forecast
8.1 Middle East & Africa OC/LEP Market: Snapshot
8.2 Middle East & Africa OC/LEP Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa OC/LEP Market: Key Factors
8.4 Middle East and Africa OC/LEP Market: Segment Analysis
8.5 Middle East & Africa OC/LEP Market Segmentation: By Type
8.5.1 Middle East & Africa OC/LEP Market, By Type Overview
8.5.2 Middle East & Africa OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East & Africa OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East & Africa OC/LEP Market Segmentation: By Distribution Channel
8.6.1 Middle East & Africa OC/LEP Market, By Distribution Channel Overview
8.6.2 Middle East & Africa OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on OC/LEP Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of OC/LEP Market
11.4 Company Profiles
11.4.1 Johnson & Johnson
11.4.2 Sanofi
11.4.3 Novartis
11.4.4 Pfizer
11.4.5 Bayer AG
11.4.6 Merck & Co., Inc.
11.4.7 Teva Pharmaceuticals
11.4.8 Abbvie
11.4.9 Viatris
11.4.10 Cipla
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Global number of women of reproductive age contraceptive use and unmet need 1990 and 2021 (millions)
Figure 2: Contraceptive use and unmet need for family planning among women with a need for family planning, world and by region, 2021 in percent
Figure 3: Global OC/LEP Market Size, By Value, 2020-2023 (USD Billion)
Figure 4: Global OC/LEP Market Size, By Value, 2024-2030 (USD Billion)
Figure 5: Global OC/LEP Market Share, By Distribution Channel, 2023 (%)
Figure 6: Market Attractiveness Analysis of Global OC/LEP Market, By Type (2024-2030)
Figure 7: Global OC/LEP Market Size, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 8: Global OC/LEP Market Absolute Opportunity, By Combination Contraceptives Pills, 2020-2030 (USD Billion)
Figure 9: Global OC/LEP Market Size, By Progestin-only Pills, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 10: Global OC/LEP Market Absolute Opportunity, By Progestin-only Pills, 2020-2030 (USD Billion)
Figure 11: Market Attractiveness Analysis of Global OC/LEP Market, By Distribution Channel (2024-2030)
Figure 12: Global OC/LEP Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 13: Global OC/LEP Market Absolute Opportunity, By Hospital Pharmacies, 2020-2030 (USD Billion)
Figure 14: Global OC/LEP Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 15: Global OC/LEP Market Absolute Opportunity, By Retail Pharmacies, 2020-2030 (USD Billion)
Figure 16: Global OC/LEP Market Size, By Other Distribution Channels, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 17: Global OC/LEP Market Absolute Opportunity, By Other Distribution Channels, 2020-2030 (USD Billion)
Figure 18: Americas OC/LEP Market Size, By Value, 2020H-2030F (USD Billion)
Figure 19: Americas OC/LEP Market Share, By Distribution Channel, 2023 (%)
Figure 20: Americas OC/LEP Market, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 21: Americas OC/LEP Market, By Progestin-only Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 22: Americas OC/LEP Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 23: Americas OC/LEP Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 24: Americas OC/LEP Market, By Other Distribution Channels, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 25: United States OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 26: United States OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 27: United States OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 28: United States OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 29: Canada OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 30: Canada OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 31: Canada OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 32: Canada OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 33: Rest of Americas OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 34: Rest of Americas OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 35: Rest of Americas OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 36: Rest of Americas OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 37: Europe OC/LEP Market Size, By Value, 2020H-2030F (USD Billion)
Figure 38: Europe OC/LEP Market Share, By Distribution Channel, 2023 (%)
Figure 39: Europe OC/LEP Market, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 40: Europe OC/LEP Market, By Progestin-only Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 41: Europe OC/LEP Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Europe OC/LEP Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Europe OC/LEP Market, By Other Distribution Channels, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: United Kingdom OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 45: United Kingdom OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 46: United Kingdom OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 47: United Kingdom OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 48: Germany OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 49: Germany OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 50: Germany OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 51: Germany OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 52: France OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 53: France OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 54: France OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 55: France OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 56: Italy OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 57: Italy OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 58: Italy OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 59: Italy OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 60: Netherlands OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 61: Netherlands OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 62: Netherlands OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 63: Netherlands OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 64: Rest of Europe OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 65: Rest of Europe OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 66: Rest of Europe OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 67: Rest of Europe OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 68: Asia Pacific OC/LEP Market Size, By Value, 2020H-2030F (USD Billion)
Figure 69: Asia Pacific OC/LEP Market Share, By Distribution Channel, 2023 (%)
Figure 70: Asia Pacific OC/LEP Market, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 71: Asia Pacific OC/LEP Market, By Progestin-only Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 72: Asia Pacific OC/LEP Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 73: Asia Pacific OC/LEP Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 74: Asia Pacific OC/LEP Market, By Other Distribution Channels, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 75: China OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 76: China OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 77: China OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 78: China OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 79: Japan OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 80: Japan OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 81: Japan OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 82: Japan OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 83: India OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 84: India OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 85: India OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 86: India OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 87: Rest of Asia Pacific OC/LEP Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 88: Rest of Asia Pacific OC/LEP Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 89: Rest of Asia Pacific OC/LEP Market Share, By Type, By Value, 2023 (%)
Figure 90: Rest of Asia Pacific OC/LEP Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 91: Middle East and Africa OC/LEP Market Size, By Value, 2020H-2030F (USD Billion)
Figure 92: Middle East and Africa OC/LEP Market Share, By Distribution Channel, 2023 (%)
Figure 93: Middle East and Africa OC/LEP Market, By Combination Contraceptives Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 94: Middle East and Africa OC/LEP Market, By Progestin-only Pills, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 95: Middle East and Africa OC/LEP Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 96: Middle East and Africa OC/LEP Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 97: Middle East and Africa OC/LEP Market, By Other Distribution Channels, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 98: Market Share of Prominent Companies of OC/LEP Market, 2023 (%)
Figure 99: Johnson & Johnson Revenue, 2021-2023 (USD Million)
Figure 100: Johnson & Johnson Revenue, By Geographical Segments, 2023 (%)
Figure 101: Johnson & Johnson Revenue, By Business Segments, 2023 (%)
Figure 102: Sanofi Revenues, 2020-2022 (USD Million)
Figure 103: Sanofi Revenues, By Geographic Segments, 2022 (%)
Figure 104: Sanofi Revenue , By Business Segments, 2022 (%)
Figure 105: Novartis Revenues, 2021-2023 (USD Million)
Figure 106: Novartis Revenues, By Geographic Segments, 2023 (%)
Figure 107: Novartis Revenue , By Business Segments, 2023 (%)
Figure 108: Pfizer Revenues, 2020-2022 (USD Million)
Figure 109: Pfizer Revenues, By Business Segments, 2023 (%)
Figure 110: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
Figure 111: Bayer AG Revenues 2021-2023(USD Million)
Figure 112: Bayer AG Revenues, By Geographic Segments, 2023 (%)
Figure 113: Bayer AG Revenues, By Business Segments, 2023 (%)
Figure 114: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 115: Merck & Co., Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 116: Merck & Co., Inc. Revenue , By Business Segments, 2023 (%)
Figure 117: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 118: Teva Pharmaceuticals Revenue , By Geographical Segments, 2022 (%)
Figure 119: AbbVie Inc. Revenues, 2021-2023 (USD Million)
Figure 120: AbbVie Inc. Revenue, Product Sales by Business Segment, 2023 (%)
Figure 121: AbbVie Inc. Revenue , By Geographical Segments, 2023 (%)
Figure 122: Viatris Revenue, 2021-2023 (USD Million)
Figure 123: Viatris Revenue, By Geographical Segments, 2023 (%)
Figure 124: Viatris Revenue, By Business Segments, 2023 (%)
Figure 125: Cipla Revenues, 2021-2023 (USD Million)
Figure 126: Cipla Revenues, By Geographic Segments, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: Unintended pregnancy and abortion rates, by region, 2015-2019
Table A3: United States OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A4: United States OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A5: United States OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A6: United States OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A7: Canada OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A8: Canada OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A9: Canada OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A10: Canada OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A11: Rest of Americas OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A12: Rest of Americas OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A13: Rest of Americas OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A14: Rest of Americas OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A15: United Kingdom OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A16: United Kingdom OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A17: United Kingdom OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A18: United Kingdom OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A19: Germany OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A20: Germany OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A21: Germany OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A22: Germany OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A23: France OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A24: France OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A25: France OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A26: France OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A27: Italy OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A28: Italy OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A29: Italy OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A30: Italy OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A31: Netherlands OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A32: Netherlands OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A33: Netherlands OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A34: Netherlands OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A35: Rest of Europe OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A36: Rest of Europe OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A37: Rest of Europe OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A38: Rest of Europe OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A39: China OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A40: China OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A41: China OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A42: China OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A43: Japan OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A44: Japan OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A45: Japan OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A46: Japan OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A47: India OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A48: India OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A49: India OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A50: India OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A51: Rest of Asia Pacific OC/LEP Market, By Type, By Value, 2020-2023 (USD Billion)
Table A52: Rest of Asia Pacific OC/LEP Market, By Type, By Value, 2024-2030 (USD Billion)
Table A53: Rest of Asia Pacific OC/LEP Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A54: Rest of Asia Pacific OC/LEP Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A55: Johnson & Johnson Key Company Financials, 2021-2023
Table A56: Sanofi Key Financials, 2020-2022
Table A57: Novartis Key Financials, 2021-2023
Table A58: Pfizer Key Financials, 2021-2023
Table A59: Bayer AG Key Financials, 2021-2023
Table A60: Merck & Co., Inc. Key Financials, 2021-2023
Table A61: Teva Pharmaceuticals Key Financials, 2021-2023
Table A62: AbbVie Inc. Key Company Financials, 2021-2023
Table A63: Viatris Key Company Financials, 2021-2023
Table A64: Cipla Key Financials, 2020-2022

Companies Mentioned

  • Johnson & Johnson
  • Sanofi
  • Novartis
  • Pfizer
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceuticals
  • Abbvie
  • Viatris
  • Cipla